PRRT2-related disorders: further PKD and ICCA cases and review of the literature.

Standard

PRRT2-related disorders: further PKD and ICCA cases and review of the literature. / Becker, Felicitas; Schubert, Julian; Striano, Pasquale; Anttonen, Anna-Kaisa; Liukkonen, Elina; Gaily, Eija; Gerloff, Christian; Müller, Stephan; Heußinger, Nicole; Kellinghaus, Christoph; Robbiano, Angela; Polvi, Anne; Zittel, Simone; Oertzen, von; Tim, J; Rostasy, Kevin; Schöls, Ludger; Warner, Tom; Münchau, Alexander; Lehesjoki, Anna-Elina; Zara, Federico; Lerche, Holger; Weber, Yvonne G.

in: J NEUROL, Jahrgang 260, Nr. 5, 5, 2013, S. 1234-1244.

Publikationen: SCORING: Beitrag in Fachzeitschrift/ZeitungSCORING: ZeitschriftenaufsatzForschungBegutachtung

Harvard

Becker, F, Schubert, J, Striano, P, Anttonen, A-K, Liukkonen, E, Gaily, E, Gerloff, C, Müller, S, Heußinger, N, Kellinghaus, C, Robbiano, A, Polvi, A, Zittel, S, Oertzen, V, Tim, J, Rostasy, K, Schöls, L, Warner, T, Münchau, A, Lehesjoki, A-E, Zara, F, Lerche, H & Weber, YG 2013, 'PRRT2-related disorders: further PKD and ICCA cases and review of the literature.', J NEUROL, Jg. 260, Nr. 5, 5, S. 1234-1244. <http://www.ncbi.nlm.nih.gov/pubmed/23299620?dopt=Citation>

APA

Becker, F., Schubert, J., Striano, P., Anttonen, A-K., Liukkonen, E., Gaily, E., Gerloff, C., Müller, S., Heußinger, N., Kellinghaus, C., Robbiano, A., Polvi, A., Zittel, S., Oertzen, V., Tim, J., Rostasy, K., Schöls, L., Warner, T., Münchau, A., ... Weber, Y. G. (2013). PRRT2-related disorders: further PKD and ICCA cases and review of the literature. J NEUROL, 260(5), 1234-1244. [5]. http://www.ncbi.nlm.nih.gov/pubmed/23299620?dopt=Citation

Vancouver

Becker F, Schubert J, Striano P, Anttonen A-K, Liukkonen E, Gaily E et al. PRRT2-related disorders: further PKD and ICCA cases and review of the literature. J NEUROL. 2013;260(5):1234-1244. 5.

Bibtex

@article{7b740d71215e44679ded611be5919ef7,
title = "PRRT2-related disorders: further PKD and ICCA cases and review of the literature.",
abstract = "Recent studies reported mutations in the gene encoding the proline-rich transmembrane protein 2 (PRRT2) to be causative for paroxysmal kinesigenic dyskinesia (PKD), PKD combined with infantile seizures (ICCA), and benign familial infantile seizures (BFIS). PRRT2 is a presynaptic protein which seems to play an important role in exocytosis and neurotransmitter release. PKD is the most common form of paroxysmal movement disorder characterized by recurrent brief involuntary hyperkinesias triggered by sudden movements. Here, we sequenced PRRT2 in 14 sporadic and 8 familial PKD and ICCA cases of Caucasian origin and identified three novel mutations (c.919C>T/p.Gln307, c.388delG/p.Ala130Profs 46, c.884G>A/p.Arg295Gln) predicting two truncated proteins and one probably damaging point mutation. A review of all published cases is also included. PRRT2 mutations occur more frequently in familial forms of PRRT2-related syndromes (80-100 %) than in sporadic cases (33-46 %) suggesting further heterogeneity in the latter. PRRT2 mutations were rarely described in other forms of paroxysmal dyskinesias deviating from classical PKD, as we report here in one ICCA family without kinesigenic triggers. Mutations are exclusively found in two exons of the PRRT2 gene at a high rate across all syndromes and with one major mutation (c.649dupC) in a mutational hotspot of nine cytosines, which is responsible for 57 % of all cases in all phenotypes. We therefore propose that genetic analysis rapidly performed in early stages of the disease is highly cost-effective and can help to avoid further unnecessary diagnostic and therapeutic interventions.",
author = "Felicitas Becker and Julian Schubert and Pasquale Striano and Anna-Kaisa Anttonen and Elina Liukkonen and Eija Gaily and Christian Gerloff and Stephan M{\"u}ller and Nicole Heu{\ss}inger and Christoph Kellinghaus and Angela Robbiano and Anne Polvi and Simone Zittel and von Oertzen and J Tim and Kevin Rostasy and Ludger Sch{\"o}ls and Tom Warner and Alexander M{\"u}nchau and Anna-Elina Lehesjoki and Federico Zara and Holger Lerche and Weber, {Yvonne G}",
year = "2013",
language = "English",
volume = "260",
pages = "1234--1244",
journal = "J NEUROL",
issn = "0340-5354",
publisher = "D. Steinkopff-Verlag",
number = "5",

}

RIS

TY - JOUR

T1 - PRRT2-related disorders: further PKD and ICCA cases and review of the literature.

AU - Becker, Felicitas

AU - Schubert, Julian

AU - Striano, Pasquale

AU - Anttonen, Anna-Kaisa

AU - Liukkonen, Elina

AU - Gaily, Eija

AU - Gerloff, Christian

AU - Müller, Stephan

AU - Heußinger, Nicole

AU - Kellinghaus, Christoph

AU - Robbiano, Angela

AU - Polvi, Anne

AU - Zittel, Simone

AU - Oertzen, von

AU - Tim, J

AU - Rostasy, Kevin

AU - Schöls, Ludger

AU - Warner, Tom

AU - Münchau, Alexander

AU - Lehesjoki, Anna-Elina

AU - Zara, Federico

AU - Lerche, Holger

AU - Weber, Yvonne G

PY - 2013

Y1 - 2013

N2 - Recent studies reported mutations in the gene encoding the proline-rich transmembrane protein 2 (PRRT2) to be causative for paroxysmal kinesigenic dyskinesia (PKD), PKD combined with infantile seizures (ICCA), and benign familial infantile seizures (BFIS). PRRT2 is a presynaptic protein which seems to play an important role in exocytosis and neurotransmitter release. PKD is the most common form of paroxysmal movement disorder characterized by recurrent brief involuntary hyperkinesias triggered by sudden movements. Here, we sequenced PRRT2 in 14 sporadic and 8 familial PKD and ICCA cases of Caucasian origin and identified three novel mutations (c.919C>T/p.Gln307, c.388delG/p.Ala130Profs 46, c.884G>A/p.Arg295Gln) predicting two truncated proteins and one probably damaging point mutation. A review of all published cases is also included. PRRT2 mutations occur more frequently in familial forms of PRRT2-related syndromes (80-100 %) than in sporadic cases (33-46 %) suggesting further heterogeneity in the latter. PRRT2 mutations were rarely described in other forms of paroxysmal dyskinesias deviating from classical PKD, as we report here in one ICCA family without kinesigenic triggers. Mutations are exclusively found in two exons of the PRRT2 gene at a high rate across all syndromes and with one major mutation (c.649dupC) in a mutational hotspot of nine cytosines, which is responsible for 57 % of all cases in all phenotypes. We therefore propose that genetic analysis rapidly performed in early stages of the disease is highly cost-effective and can help to avoid further unnecessary diagnostic and therapeutic interventions.

AB - Recent studies reported mutations in the gene encoding the proline-rich transmembrane protein 2 (PRRT2) to be causative for paroxysmal kinesigenic dyskinesia (PKD), PKD combined with infantile seizures (ICCA), and benign familial infantile seizures (BFIS). PRRT2 is a presynaptic protein which seems to play an important role in exocytosis and neurotransmitter release. PKD is the most common form of paroxysmal movement disorder characterized by recurrent brief involuntary hyperkinesias triggered by sudden movements. Here, we sequenced PRRT2 in 14 sporadic and 8 familial PKD and ICCA cases of Caucasian origin and identified three novel mutations (c.919C>T/p.Gln307, c.388delG/p.Ala130Profs 46, c.884G>A/p.Arg295Gln) predicting two truncated proteins and one probably damaging point mutation. A review of all published cases is also included. PRRT2 mutations occur more frequently in familial forms of PRRT2-related syndromes (80-100 %) than in sporadic cases (33-46 %) suggesting further heterogeneity in the latter. PRRT2 mutations were rarely described in other forms of paroxysmal dyskinesias deviating from classical PKD, as we report here in one ICCA family without kinesigenic triggers. Mutations are exclusively found in two exons of the PRRT2 gene at a high rate across all syndromes and with one major mutation (c.649dupC) in a mutational hotspot of nine cytosines, which is responsible for 57 % of all cases in all phenotypes. We therefore propose that genetic analysis rapidly performed in early stages of the disease is highly cost-effective and can help to avoid further unnecessary diagnostic and therapeutic interventions.

M3 - SCORING: Journal article

VL - 260

SP - 1234

EP - 1244

JO - J NEUROL

JF - J NEUROL

SN - 0340-5354

IS - 5

M1 - 5

ER -